BIIB vs GAP · P/E 21, rev $9.89B vs P/E 9.9, rev $15.09B
Biogen Inc (BIIB) versus The Gap, Inc. (GAP) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
The Gap, Inc. (GAP) is a apparel retail company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported GAP revenue for 2025-02-01 was $15.09B. Net income was $844.0M. Revenue was up 1.3% from 2024-02-03 to 2025-02-01. GAP currently screens at market cap $7.73B and trailing P/E 9.9.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. GAP currently screens at market cap $7.73B and trailing P/E 9.9.
Not investment advice. Open the BIIB and GAP stock pages for the full models.
Not investment advice.